ETF Holdings Breakdown of CRMD

CRMD institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-09-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	66,116	USD 747,111
2025-09-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	37,683	USD 425,818
2025-09-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	40,060	USD 452,678
2025-09-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	40,060	USD 452,678
2025-09-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,532	USD 17,312 1.6%
Total =		185,451	USD 2,095,597

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with CRMD

Analysts Set CorMedix Inc (NASDAQ:CRMD) Price Target at $17.33

CorMedix Inc (NASDAQ:CRMD – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven analysts that are presently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the […] - 2025-09-01 03:01:01

CorMedix (NASDAQ:CRMD) Lowered to “Buy” Rating by Wall Street Zen

CorMedix (NASDAQ:CRMD – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday. A number of other equities analysts have also recently weighed in on the stock. D Boral Capital cut shares of CorMedix […] - 2025-08-11 05:06:55

CorMedix (NASDAQ:CRMD) Given New $17.00 Price Target at HC Wainwright

CorMedix (NASDAQ:CRMD – Free Report) had its target price decreased by HC Wainwright from $20.00 to $17.00 in a report released on Friday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for CorMedix’s Q3 2025 earnings at $0.33 EPS. A number of other equities analysts have […] - 2025-08-11 04:08:44

Arizona State Retirement System Makes New $107,000 Investment in CorMedix Inc (NASDAQ:CRMD)

Arizona State Retirement System acquired a new position in CorMedix Inc (NASDAQ:CRMD – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 17,396 shares of the company’s stock, valued at approximately $107,000. A number of other institutional investors […] - 2025-07-24 04:38:52

Teacher Retirement System of Texas Invests $98,000 in CorMedix Inc (NASDAQ:CRMD)

Teacher Retirement System of Texas bought a new stake in CorMedix Inc (NASDAQ:CRMD – Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 15,981 shares of the company’s stock, valued at approximately $98,000. A number of other institutional investors have also […] - 2025-07-22 04:12:50

CorMedix Inc (NASDAQ:CRMD) Receives $17.14 Average Target Price from Analysts

Shares of CorMedix Inc (NASDAQ:CRMD – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eight analysts that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation […] - 2025-07-15 03:51:08

Essex Financial Services Inc. Buys New Shares in CorMedix Inc (NASDAQ:CRMD)

Essex Financial Services Inc. purchased a new position in CorMedix Inc (NASDAQ:CRMD – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 10,263 shares of the company’s stock, valued at approximately $63,000. Several other hedge funds also recently made changes to their positions […] - 2025-07-03 06:15:00

CorMedix (NASDAQ:CRMD) Cut to “Hold” at D Boral Capital

D Boral Capital downgraded shares of CorMedix (NASDAQ:CRMD – Free Report) from a strong-buy rating to a hold rating in a research note released on Monday morning,Zacks.com reports. Several other analysts have also recently commented on CRMD. D. Boral Capital cut CorMedix from a “buy” rating to a “hold” rating in a research report on […] - 2025-07-03 05:23:10

Needham & Company LLC Raises CorMedix (NASDAQ:CRMD) Price Target to $20.00

CorMedix (NASDAQ:CRMD – Get Free Report) had its price objective increased by research analysts at Needham & Company LLC from $15.00 to $20.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s target price would suggest a potential upside of […] - 2025-06-26 02:48:48

D. Boral Capital Reaffirms Buy Rating for CorMedix (NASDAQ:CRMD)

CorMedix (NASDAQ:CRMD – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at D. Boral Capital in a report released on Monday,Benzinga reports. They currently have a $15.00 target price on the stock. D. Boral Capital’s price target would suggest a potential downside of 4.58% from the company’s current price. Several other […] - 2025-06-25 02:36:50

CorMedix Inc (NASDAQ:CRMD) Receives $15.00 Average Target Price from Analysts

Shares of CorMedix Inc (NASDAQ:CRMD – Get Free Report) have been assigned an average rating of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average […] - 2025-06-18 02:26:51

Northern Trust Corp Has $4.14 Million Stake in CorMedix Inc. (NASDAQ:CRMD)

Northern Trust Corp raised its position in CorMedix Inc. (NASDAQ:CRMD – Free Report) by 14.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 511,565 shares of the company’s stock after purchasing an additional 64,243 shares during the quarter. Northern Trust Corp’s holdings in […] - 2025-05-23 05:26:53

CorMedix Inc. (NASDAQ:CRMD) Given Consensus Recommendation of “Buy” by Brokerages

Shares of CorMedix Inc. (NASDAQ:CRMD – Get Free Report) have earned an average rating of “Buy” from the seven analysts that are currently covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among […] - 2025-05-21 04:48:43

D. E. Shaw & Co. Inc. Has $3.62 Million Holdings in CorMedix Inc. (NASDAQ:CRMD)

D. E. Shaw & Co. Inc. raised its stake in CorMedix Inc. (NASDAQ:CRMD – Free Report) by 39.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 446,414 shares of the company’s stock after acquiring an additional 125,425 shares during the quarter. D. […] - 2025-05-19 05:10:50

CorMedix (NASDAQ:CRMD) Sees Unusually-High Trading Volume on Strong Earnings

CorMedix Inc. (NASDAQ:CRMD – Get Free Report) saw an uptick in trading volume on Wednesday following a stronger than expected earnings report. 3,436,993 shares were traded during mid-day trading, an increase of 220% from the previous session’s volume of 1,074,103 shares.The stock last traded at $11.38 and had previously closed at $11.16. The company reported […] - 2025-05-09 02:58:43

CorMedix (NASDAQ:CRMD) Shares Gap Up on Earnings Beat

CorMedix Inc. (NASDAQ:CRMD – Get Free Report)’s share price gapped up prior to trading on Tuesday following a better than expected earnings announcement. The stock had previously closed at $9.03, but opened at $9.59. CorMedix shares last traded at $10.36, with a volume of 716,204 shares traded. The company reported $0.30 EPS for the quarter, […] - 2025-05-08 02:25:25

CorMedix Inc. (NASDAQ:CRMD) Receives $14.50 Consensus PT from Brokerages

Shares of CorMedix Inc. (NASDAQ:CRMD – Get Free Report) have received an average rating of “Buy” from the seven analysts that are covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1 year target price among […] - 2025-05-01 04:54:49

CorMedix Inc. (NASDAQ:CRMD) Shares Sold by Wellington Management Group LLP

Wellington Management Group LLP lessened its position in shares of CorMedix Inc. (NASDAQ:CRMD – Free Report) by 1.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 178,786 shares of the company’s stock after selling 2,162 shares during the period. Wellington Management Group LLP’s […] - 2025-04-14 04:50:52

D. Boral Capital Reaffirms “Buy” Rating for CorMedix (NASDAQ:CRMD)

D. Boral Capital reaffirmed their buy rating on shares of CorMedix (NASDAQ:CRMD – Free Report) in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a $15.00 target price on the stock. Several other equities analysts also recently weighed in on CRMD. Royal Bank of Canada restated an “outperform” rating […] - 2025-04-11 04:32:51

CorMedix Logs Q1 Prel. Revenue Of $39 Mln

(RTTNews) - CorMedix Inc. (CRMD), a biopharmaceutical company, Tuesday reported preliminary revenue of $39 million for the first quarter. In the previous-year quarter, the company did not receive any revenue. - 2025-04-08 09:01:32

Intech Investment Management LLC Has $195,000 Stock Position in CorMedix Inc. (NASDAQ:CRMD)

Intech Investment Management LLC boosted its stake in shares of CorMedix Inc. (NASDAQ:CRMD – Free Report) by 63.7% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 24,063 shares of the company’s stock after purchasing an additional 9,368 shares during the quarter. Intech Investment Management LLC’s holdings in CorMedix were worth $195,000 at […] - 2025-03-28 07:12:48

CorMedix (NASDAQ:CRMD) Earns Buy Rating from D. Boral Capital

D. Boral Capital reaffirmed their buy rating on shares of CorMedix (NASDAQ:CRMD – Free Report) in a research note issued to investors on Tuesday morning,Benzinga reports. They currently have a $15.00 target price on the stock. Several other research analysts have also commented on CRMD. Royal Bank of Canada lifted their price target on CorMedix […] - 2025-03-26 04:52:44

Financial Comparison: CorMedix (NASDAQ:CRMD) versus Lexicon Pharmaceuticals (NASDAQ:LXRX)

CorMedix (NASDAQ:CRMD – Get Free Report) and Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations. Profitability This table compares CorMedix and Lexicon Pharmaceuticals’ […] - 2025-03-18 03:56:56

CorMedix Inc. (NASDAQ:CRMD) Receives Consensus Recommendation of “Buy” from Analysts

Shares of CorMedix Inc. (NASDAQ:CRMD – Get Free Report) have been assigned an average recommendation of “Buy” from the eight research firms that are covering the firm, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price […] - 2025-03-12 04:10:58

Aigen Investment Management LP Acquires New Holdings in CorMedix Inc. (NASDAQ:CRMD)

Aigen Investment Management LP acquired a new stake in shares of CorMedix Inc. (NASDAQ:CRMD – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 11,545 shares of the company’s stock, valued at approximately $94,000. Several other hedge funds and other […] - 2025-03-11 06:24:55

Steward Partners Investment Advisory LLC Grows Position in CorMedix Inc. (NASDAQ:CRMD)

Steward Partners Investment Advisory LLC boosted its position in CorMedix Inc. (NASDAQ:CRMD – Free Report) by 2.2% during the 4th quarter, Holdings Channel reports. The fund owned 149,834 shares of the company’s stock after acquiring an additional 3,221 shares during the quarter. Steward Partners Investment Advisory LLC’s holdings in CorMedix were worth $1,214,000 as of […] - 2025-03-10 06:19:02

Leerink Partnrs Upgrades CorMedix (NASDAQ:CRMD) to Strong-Buy

Leerink Partnrs upgraded shares of CorMedix (NASDAQ:CRMD – Free Report) to a strong-buy rating in a research note issued to investors on Friday morning,Zacks.com reports. Several other research firms have also issued reports on CRMD. Royal Bank of Canada lifted their price objective on shares of CorMedix from $11.00 to $12.00 and gave the company […] - 2025-03-10 04:08:47

CorMedix (NASDAQ:CRMD) vs. Helix BioPharma (OTCMKTS:HBPCF) Financial Contrast

Helix BioPharma (OTCMKTS:HBPCF – Get Free Report) and CorMedix (NASDAQ:CRMD – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk. Analyst Recommendations This is a breakdown of current […] - 2025-02-05 04:26:43

China Universal Asset Management Co. Ltd. Makes New Investment in CorMedix Inc. (NASDAQ:CRMD)

China Universal Asset Management Co. Ltd. purchased a new position in shares of CorMedix Inc. (NASDAQ:CRMD – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 12,866 shares of the company’s stock, valued at approximately $104,000. Several other institutional investors and hedge funds have […] - 2025-02-04 07:15:10

Back to Listing

Disclaimer